What are the opportunities for the domestic anti-new crown drug industry chain of Xinhua Pharmaceutical's Qilian board

  • Post date May 9, 2022 — 13:06 Post Lock Login to View

Key Data Concepts:   
? These are the company names, stock quotes, topics, and entities related to this data.

000739 000756 002014 002022 300122 300198 300497 300713 Apeloa Pharmaceutical China Resources Double-Crane Pharmaceutical Chongqing Zhifei Biological Products Dali Pharmaceutical Everbright Securities Fujian Superpipe Huangshan Novel Jiangxi Fushine Pharmaceutical Shandong Xinhua Pharmaceutical Company Limited Shanghai Kehua Bio-Engineering Shenzhenrease Technology Zhejiang Ausun Pharmaceutical Zhejiang Huahai Pharmaceutical Zhejiang Jiuzhou Pharmaceutical Research, Development Health, Beauty Product Pharmaceutical Paper, Packaging Product Market, Exchange Securities Epidemic Medicine Vaccines Workplace Health, Safety Food, Drink Enthusiasm House, Home Trend Food, Drink Regulations Death, Dying Welfare Small, Medium Enterprise Health

Full Data

?
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets


Join Now!

Need this critical market data?

Access thousands of market events, data points, and news articles!


Already have an account?
Login



Related Data